Literature DB >> 281446

Antibody-induced loss of Friend virus leukemia cell surface antigens occurs during progression of erythroleukemia in F1 mice.

D Doig, B Chesebro.   

Abstract

Friend virus (FV)-induced leukemic spleen cells from (B10.A X A)F1 mice were found to lose sensitivity to antibody-mediated lysis during progression of erythroleukemia. This was correlated with a 78% loss of FV-induced cell surface antigens as determined by quantitative absorption of cytotoxic antibodies and with a decreased percentage of leukemic spleen cells showing membrane immunofluorescence with anti-FV antibody. Antigen loss was observed only with virus-induced antigens, and was limited to antigens expressed on the cell surface. FV-induced antigens were regained when low-antigen leukemia cells from late stages of the leukemia were transferred to lethally irradiated nonimmune recipients, but not when these cells were transferred to hyperimmune lethally irradiated recipients. Conversely, when high-antigen leukemic spleen cells from early stages of the erythroleukemia were transferred to hyperimmune irradiated recipients, antigen loss was induced. The immune response to virus-induced antigens appeared to be involved in causing the antigenic changes observed on leukemia cells in this system.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 281446      PMCID: PMC2185041          DOI: 10.1084/jem.148.5.1109

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  15 in total

1.  ASSAY FOR FRIEND LEUKEMIA VIRUS: RAPID QUANTITATIVE METHOD BASED ON ENUMERATION OF MACROSCOPIC SPLEEN FOCI IN MICE.

Authors:  A A AXELRAD; R A STEEVES
Journal:  Virology       Date:  1964-11       Impact factor: 3.616

2.  Modulation of fetal antigen(s) in mouse leukemia cells.

Authors:  J R Ortaldo; C C Ting; R B Herberman
Journal:  Cancer Res       Date:  1974-06       Impact factor: 12.701

3.  Transformation of spleen cells three hours after infection in vivo with Friend leukemia virus.

Authors:  G B Rossi; G Cudkowicz; C Friend
Journal:  J Natl Cancer Inst       Date:  1973-01       Impact factor: 13.506

4.  Immunologic modification: a basic survival mechanism.

Authors:  B B Jacobs; D E Uphoff
Journal:  Science       Date:  1974-08-16       Impact factor: 47.728

5.  Characterization of Ia8 antigen, thy-1.2 antigen, complement receptors, and virus production in a group of murine virus-induced leukemia cell lines.

Authors:  B Chesebro; K Wehrly; K Chesebro; J Portis
Journal:  J Immunol       Date:  1976-10       Impact factor: 5.422

6.  Cell-free transmission in adult Swiss mice of a disease having the character of a leukemia.

Authors:  C FRIEND
Journal:  J Exp Med       Date:  1957-04-01       Impact factor: 14.307

7.  Antigenic modulation. Loss of TL antigen from cells exposed to TL antibody. Study of the phenomenon in vitro.

Authors:  L J Old; E Stockert; E A Boyse; J H Kim
Journal:  J Exp Med       Date:  1968-03-01       Impact factor: 14.307

8.  Host genetic control of recovery from Friend leukemia virus-induced splenomegaly: mapping of a gene within the major histocompatability complex.

Authors:  B Chesebro; K Wehrly; J Stimpfling
Journal:  J Exp Med       Date:  1974-12-01       Impact factor: 14.307

9.  Antigenic modulation of Friend virus erythroleukemic cells in vitro by serum from mice with dormant erythroleukemia.

Authors:  E V Genovesi; P A Marx; E F Wheelock
Journal:  J Exp Med       Date:  1977-08-01       Impact factor: 14.307

10.  Induction of partial immunologic tolerance in rats and progressive loss of cellular antigenicity in Gross virus lymphoma.

Authors:  H L Ioachim; S E Keller; B H Dorsett; A Pearse
Journal:  J Exp Med       Date:  1974-06-01       Impact factor: 14.307

View more
  9 in total

1.  Antibody-induced modulation of Friend virus cell surface antigens decreases virus production by persistent erythroleukemia cells: influence of the Rfv-3 gene.

Authors:  B Chesebro; K Wehrly; D Doig; J Nishio
Journal:  Proc Natl Acad Sci U S A       Date:  1979-11       Impact factor: 11.205

2.  Replication-defective Friend murine leukemia virus particles containing uncleaved gag polyproteins and decreased levels of envelope glycoprotein.

Authors:  J K Collins; B Chesebro
Journal:  J Virol       Date:  1981-01       Impact factor: 5.103

3.  Antigenic modulation of lymphocytic surface immunoglobulin yielding resistance to complement-mediated lysis. I. Characterization with syngeneic and xenogeneic complements.

Authors:  J Gordon; D S Robinson; G T Stevenson
Journal:  Immunology       Date:  1981-01       Impact factor: 7.397

4.  Frequent hereditable shutdown of murine retrovirus gene expression in murine cell lines.

Authors:  R K Bestwick; C A Machida; E Polonoff; D Kabat
Journal:  Mol Cell Biol       Date:  1984-05       Impact factor: 4.272

5.  Persistence of infectious Friend virus in spleens of mice after spontaneous recovery from virus-induced erythroleukemia.

Authors:  B Chesebro; M Bloom; K Wehrly; J Nishio
Journal:  J Virol       Date:  1979-12       Impact factor: 5.103

6.  Plasma membrane glycoproteins encoded by cloned Rauscher and Friend spleen focus-forming viruses.

Authors:  M Ruta; D Kabat
Journal:  J Virol       Date:  1980-09       Impact factor: 5.103

7.  Anti-Friend virus antibody is associated with recovery from viremia and loss of viral leukemia cell-surface antigens in leukemic mice. Identification of Rfv-3 as a gene locus influencing antibody production.

Authors:  D Doig; B Chesebro
Journal:  J Exp Med       Date:  1979-07-01       Impact factor: 14.307

8.  New cell surface gp70 related to Friend mink cell focus-inducing virus is expressed on Friend virus-induced erythroleukemic spleen cells after elimination of ecotropic Friend virus gp70 in Rfv-3r/s mice.

Authors:  W J Britt; J K Collins; B Chesebro
Journal:  J Exp Med       Date:  1981-09-01       Impact factor: 14.307

9.  Influence of the murine MHC (H-2) on Friend leukemia virus-induced immunosuppression.

Authors:  R P Morrison; J Nishio; B Chesebro
Journal:  J Exp Med       Date:  1986-02-01       Impact factor: 14.307

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.